Abstract
Background: Depressive symptoms are highly prevalent, present in heterogeneous symptom patterns, and share diverse neurobiological underpinnings. Understanding the links between psychopathological symptoms and biological factors is critical in elucidating its etiology and persistence. We aimed to evaluate the utility of using symptom-brain network models to parse the heterogeneity of depressive complaints in a large adolescent sample. Methods: We used data from the third wave of the IMAGEN study, a multi-center panel cohort study involving 1317 adolescents (52.49 % female, mean ± SD age = 18.5 ± 0.7). Two network models were estimated: one including an overall depressive symptom severity sum score based on the Adolescent Depression Rating Scale (ADRS), and one incorporating individual ADRS item scores. Both networks included measures of cortical thickness in several regions (insula, cingulate, mOFC, fusiform gyrus) and hippocampal volume derived from neuroimaging. Results: The network based on individual item scores revealed associations between cortical thickness measures and specific depressive complaints, obscured when using an aggregate depression severity score. Notably, the insula's cortical thickness showed negative associations with cognitive dysfunction (partial cor. = −0.15); the cingulate's cortical thickness showed negative associations with feelings of worthlessness (partial cor. = −0.10), and mOFC was negatively associated with anhedonia (partial cor. = −0.05). Limitations: This cross-sectional study relied on the self-reported assessment of depression complaints and used a non-clinical sample with predominantly healthy participants (19 % with depression or sub-threshold depression). Conclusions: This study showcases the utility of network models in parsing heterogeneity in depressive complaints, linking individual complaints to specific neural substrates. We outline the next steps to integrate neurobiological and cognitive markers to unravel MDD's phenotypic heterogeneity.
Original language | English |
---|---|
Pages (from-to) | 140-144 |
Number of pages | 5 |
Journal | Journal of Affective Disorders |
Volume | 359 |
Early online date | 14 May 2024 |
DOIs | |
Publication status | Published - 15 Aug 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Author(s)
Funding
This work received support from the following sources: the European Union -funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) ( LSHM-CT-2007-037286 ), the Horizon 2020 funded ERC Advanced Grant \u2018STRATIFY\u2019 (Brain network based stratification of reinforcement-related disorders) ( 695313 ), Human Brain Project (HBP SGA 2, 785907 , and HBP SGA 3, 945539 ), the Medical Research Council Grant \u2018c-VEDA\u2019 (Consortium on Vulnerability to Externalizing Disorders and Addictions) ( MR/N000390/1 ), the National Institute of Health (NIH) ( R01DA049238 , A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London , the Bundesministeriumf\u00FCr Bildung und Forschung (BMBF grants 01GS08152 ; 01EV0711 ; Forschungsnetz AERIAL 01EE1406A , 01EE1406B ; Forschungsnetz IMAC-Mind 01GL1745B ), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 , SFB 940 , TRR 265 , NE 1383/14-1 ), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1), the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01 ), NSFC grant 82150710554 and European Union funded project \u2018environMENTAL\u2019, grant no: 101057429 . Further support was provided by grants from: - the ANR ( ANR-12-SAMA-0004 , AAPG2019 - GeBra), the Eranet Neuron ( AF12-NEUR0008-01 - WM2NA; and ANR-18-NEUR00002-01 - ADORe), the Fondation de France ( 00081242 ), the Fondation pour la Recherche M\u00E9dicale ( DPA20140629802 ), the Mission Interminist\u00E9rielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-H\u00F4pitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l'Avenir (grant AP-RM-17-013 ), the F\u00E9d\u00E9ration pour la Recherche sur le Cerveau ; the National Institutes of Health , Science Foundation Ireland ( 16/ERCD/3797 ), U.S.A. (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1 ) and by NIH Consortium grant U54 EB020403 , supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This study is part of the project \u2018New Science of Mental Disorders\u2019 ( www.nsmd.eu ), supported by the Dutch Research Council and the Dutch Ministry of Education, Culture and Science (NWO gravitation grant number 024.004.016 ). T.F.B. was supported by an Amsterdam Brain and Cognition Project Grant. This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT-2007-037286), the Horizon 2020 funded ERC Advanced Grant \u2018STRATIFY\u2019 (Brain network based stratification of reinforcement-related disorders) (695313), Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539), the Medical Research Council Grant \u2018c-VEDA\u2019 (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the National Institute of Health (NIH) (R01DA049238, A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministeriumf\u00FCr Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A, 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940, TRR 265, NE 1383/14-1), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1), the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01), NSFC grant 82150710554 and European Union funded project \u2018environMENTAL\u2019, grant no: 101057429. Further support was provided by grants from: - the ANR (ANR-12-SAMA-0004, AAPG2019 - GeBra), the Eranet Neuron (AF12-NEUR0008-01 - WM2NA; and ANR-18-NEUR00002-01 - ADORe), the Fondation de France (00081242), the Fondation pour la Recherche M\u00E9dicale (DPA20140629802), the Mission Interminist\u00E9rielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-H\u00F4pitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l'Avenir (grant AP-RM-17-013), the F\u00E9d\u00E9ration pour la Recherche sur le Cerveau; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A. (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This study was part of the project \u2018New Science of Mental Disorders\u2019 (www.nsmd.eu), supported by the Dutch Research Council and the Dutch Ministry of Education, Culture and Science (NWO gravitation grant number 024.004.016). T.F.B. was supported by an Amsterdam Brain and Cognition Project Grant.
Funders | Funder number |
---|---|
Agence Nationale de la Recherche | |
National Institutes of Health, Science Foundation Ireland | |
Institut national de la santé et de la recherche médicale | |
National Institute for Health and Care Research | |
Fédération pour la Recherche sur le Cerveau | |
South London and Maudsley NHS Foundation Trust | |
Université Paris-Sud | |
King's College London | |
Ministerie van Onderwijs, Cultuur en Wetenschap | |
Horizon 2020 | |
National Institutes of Health | 5U54EB020403-05, R01DA049238, 1R56AG058854-01 |
National Institutes of Health | |
National Natural Science Foundation of China | 82150710554, 101057429 |
National Natural Science Foundation of China | |
Fondation de France | 00081242 |
Fondation de France | |
Fondation pour la Recherche Médicale | DPA20140629802 |
Fondation pour la Recherche Médicale | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 024.004.016 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
European Union-funded FP6 | LSHM-CT-2007-037286 |
Bundesministerium für Bildung und Forschung | 01GL1745B, 01GS08152, 01EV0711, AERIAL 01EE1406A, 01EE1406B |
Bundesministerium für Bildung und Forschung | |
Sixth Framework Programme | LSHM-CT-2007-037286 |
Sixth Framework Programme | |
Fondation de l'Avenir pour la Recherche Médicale Appliquée | AP-RM-17-013 |
Fondation de l'Avenir pour la Recherche Médicale Appliquée | |
European Commission | 101057429 |
European Commission | |
Era-Net Neuron | ANR-18-NEUR00002-01 - ADORe, AF12-NEUR0008-01 - WM2NA |
Era-Net Neuron | |
Medical Research Foundation and Medical research council | MR/R00465X/1, MR/S020306/1 |
European Research Council | 695313, 785907, 945539 |
European Research Council | |
Medical Research Council | MR/N000390/1 |
Medical Research Council | |
ANR-12-SAMA-0004 | AAPG2019 - GeBra |
National Institutes of Health, Science Foundation Ireland | 16/ERCD/3797 |
Deutsche Forschungsgemeinschaft | SM 80/7-2, NE 1383/14-1, SFB 940, TRR 265 |
Deutsche Forschungsgemeinschaft | |
Testosterone and Mental Health | RO1 MH085772-01A1 |
Keywords
- Depression symptoms
- Heterogeneity
- Network analysis
- Neural markers